05/22/2025
6:44 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Riva Alessandro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:46 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
BRANDICOURT OLIVIER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:47 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:41 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
HOOPER ANTHONY C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:42 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:44 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Dugan Margaret (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
3:45 PM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
4:37 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:53 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Capital International Investors (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
5:04 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
5:09 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for ONC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Beigene and its competitors with MarketBeat's FREE daily newsletter. |
04/28/2025
3:09 PM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
7:26 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
4:12 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
3:21 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
5:12 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form ARS | |
04/07/2025
5:03 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form DEF 14A | |
04/07/2025
5:07 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form DEFA14A | |
04/01/2025
3:27 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
3:53 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:51 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
3:43 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:51 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
| Form 144/A | |
03/10/2025
3:19 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:08 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form DEFA14A | |
03/09/2025
11:15 PM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form EFFECT | |
03/10/2025
5:02 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 424B3 | |
03/07/2025
7:17 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:26 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:19 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:20 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:22 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:24 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:14 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
4:22 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
3:48 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:17 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:07 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
8:30 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SCHEDULE 13D/A | |
03/03/2025
8:31 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
HHLR ADVISORS, LTD. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:30 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad) A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late. Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks. |
03/03/2025
3:49 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
8:43 PM | Baker Brothers Life Sciences LP (Reporting)
BeiGene, Ltd. (Subject)
Beigene (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
8:40 PM | 667, L.P. (Reporting)
BeiGene, Ltd. (Subject)
Beigene (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
8:28 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:05 PM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 10-K/A | |
02/28/2025
5:15 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form S-4/A | |
02/27/2025
5:04 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
5:12 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
3:23 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025
3:24 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Lee Chan Henry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
5:12 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:29 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
3:44 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:02 PM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:08 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:02 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 10-K/A | |
01/07/2025
3:18 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
5:05 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
4:02 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:18 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:25 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:30 PM | BAKER BROS. ADVISORS LP (Filed by)
BeiGene, Ltd. (Subject)
Beigene (Subject)
| Form SC 13D/A | |
12/10/2024
7:19 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:26 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
5:02 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:48 PM | 667, L.P. (Reporting)
BeiGene, Ltd. (Subject)
Beigene (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
8:48 PM | Baker Brothers Life Sciences LP (Reporting)
BeiGene, Ltd. (Subject)
Beigene (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
8:45 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
HHLR ADVISORS, LTD. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
3:31 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:23 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:23 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:39 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
5:03 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:05 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
5:29 PM | BeiGene, Ltd. (Filed by)
Beigene (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
| Form SC 13D/A | |
10/31/2024
4:40 PM | BeiGene, Ltd. (Filed by)
Beigene (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
| Form SCHEDULE 13D/A | |
10/28/2024
5:05 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:48 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:23 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:24 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
6:13 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:16 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Sharp Shalini (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
6:21 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
5:29 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:27 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Lee Chan Henry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
5:02 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
5:12 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
4:25 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:40 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
4:40 PM | Ball Titus B. (Reporting)
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Prepare now for May 31 event (Ad) Prepare now for May 31 event Circle May 31 on your calendar
This man grew up in a trailer in New Mexico. Today, he's a multimillionaire tech investor and entrepreneur. And he says as soon as May 31, two of the most powerful technologies of all time are set to converge, creating more millionaires in the coming years than anything else on the planet. Learn how to prepare for this $16 trillion event right here. |
09/05/2024
4:41 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:19 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
6:29 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:30 PM | BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
4:27 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:17 PM | BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:32 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
08/07/2024
5:04 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
5:07 AM | BeiGene, Ltd. (Filer)
Beigene (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Buy ONC Stock Free ONC Stock Alerts